Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Clostridium butyricum for Remission: What the Evidence Shows

This conversation evaluates the effectiveness of Clostridium butyricum for achieving remission in conditions like IBD. Based on Pillser's database, the probiotic shows promising benefits for reducing inflammation, improving gut microbiota, and enhancing treatment response, though evidence is limited to small studies.

  • I've heard Clostridium butyricum might help with remission for some condition, but what does the evidence actually say about how effective it is?

  • Here's what the evidence from Pillser's research database shows on Clostridium butyricum:

    Overview of Available Evidence

    Pillser has catalogued 10 health outcomes studied in relation to Clostridium butyricum, with most studies showing beneficial effects1.

    Key Findings by Outcome

    OutcomeStudiesEffect
    Improved Nutritional Status1 study✅ Beneficial2
    Reduced Depression Symptoms1 study✅ Beneficial3
    Reduced Anxiety1 study✅ Beneficial4
    Reduced Inflammation1 study✅ Beneficial5
    Improved Treatment Response Rate1 study✅ Beneficial6
    Improved Gut Microbiota Composition1 study✅ Beneficial7
    Reduced Fever Duration1 study✅ Beneficial8
    Reduced Body Temperature1 study✅ Beneficial9
    Increased H. pylori Eradication1 study⚪ Neutral10
    Reduced Bacteremia1 study⚪ Neutral11

    What This Means for "Remission"

    You likely heard about Clostridium butyricum in the context of inflammatory bowel disease (IBD) — conditions like ulcerative colitis or Crohn's disease where "remission" is a key treatment goal. While Pillser's database doesn't list a specific "remission" outcome, several directly relevant findings stand out:

    • Reduced Inflammation — A core mechanism for achieving and maintaining remission in IBD5.
    • Improved Treatment Response Rate — Suggests it may enhance how well patients respond to other therapies6.
    • Improved Gut Microbiota Composition — Clostridium butyricum is a butyrate-producing bacterium, and butyrate is a short-chain fatty acid that supports gut barrier function and reduces intestinal inflammation7.

    Limitations to Keep in Mind

    • Small number of studies — Most outcomes are backed by only a single study, so the evidence base is still quite preliminary.
    • No studies specifically measuring "remission" as a defined endpoint yet in Pillser's database.
    • Neutral results on bacteremia and H. pylori eradication suggest it's not a universal cure-all.

    Bottom Line

    The existing evidence is promising but limited. Clostridium butyricum appears to be beneficial for reducing inflammation, improving gut microbiota, and enhancing treatment response — all of which are relevant to achieving remission in gut-related conditions. However, with only a handful of studies available, larger and more rigorous clinical trials are needed to confirm its effectiveness for inducing or maintaining remission in specific diseases.

    Would you like me to search for specific Clostridium butyricum supplement products on Pillser, or would you like to dig deeper into any particular health outcome?

    Footnotes

    1. Pillser research database, Clostridium butyricum (probiotic) overview ↩

    2. Pillser research database, Improved Nutritional Status ↩

    3. Pillser research database, Reduced Depression Symptoms ↩

    4. Pillser research database, Reduced Anxiety ↩

    5. Pillser research database, Reduced Inflammation ↩ ↩2

    6. Pillser research database, Improved Treatment Response Rate ↩ ↩2

    7. Pillser research database, Improved Gut Microbiota Composition ↩ ↩2

    8. Pillser research database, Reduced Fever Duration ↩

    9. Pillser research database, Reduced Body Temperature ↩

    10. Pillser research database, Increased H. pylori Eradication Rate ↩

    11. Pillser research database, Reduced Bacteremia ↩

New Topic

Browse Related Questions

Back to top